Status:
COMPLETED
Impact of Aromatherapy on the Delirium of Patients in Intensive Care Unit
Lead Sponsor:
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Conditions:
Intensive Care Unit Delirium
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this monocenter randomized controlled trial is to assess the efficacy of aromatherapy to prevent delirium in patients hospitalized in an intensive care unit.
Detailed Description
Secondary objectives: 1. To assess the efficacy of aromatherapy on : * the level of consciousness, * pain, * the duration of mechanical ventilation, * the occurence of an accidental extu...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Patient hospitalized in an intensive care unit for an expected duration of at least 24 hours
- Patient requiring mechanical ventilation with initial therapeutic sedation adapted secondarily for comfort sedation, defined by a RASS score target between -2 and 0
- Patient affiliated to/beneficiary of a social security scheme
Exclusion
- Allergy to essential and/or vegetable oils
- Palliative sedation
- Foot skin injury contraindicating the application of an oil
- Moribund patient or expected death
- History of dementia
- Participation to a RIPH-1 study
- Pregnant or breastfeeding woman
- Patient under legal protection
- Patient deprived of liberty by judicial or administrative decision
Key Trial Info
Start Date :
September 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 7 2023
Estimated Enrollment :
161 Patients enrolled
Trial Details
Trial ID
NCT04529395
Start Date
September 18 2020
End Date
September 7 2023
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier de Mulhouse et de la Région Sud-Alsace
Mulhouse, France